This article provides a comprehensive overview of current methodologies to mitigate off-target effects in engineered microbial communities, a critical challenge for researchers, scientists, and drug development professionals.
This article provides a comprehensive analysis of innovative strategies to enhance the stability and efficacy of CRISPR constructs within challenging biofilm microenvironments.
This article provides a comprehensive framework for researchers, scientists, and drug development professionals exploring multiplexed CRISPR-Cas systems to combat antibiotic-resistant biofilm infections.
Pseudomonas aeruginosa biofilms are a major cause of persistent, antibiotic-resistant infections, particularly in cystic fibrosis and immunocompromised patients.
The convergence of CRISPR-Cas9 gene-editing technology with advanced nanoparticle delivery systems represents a paradigm shift in combating biofilm-associated antimicrobial resistance.
The escalating crisis of antibiotic-resistant biofilm infections demands innovative therapeutic strategies beyond conventional antibiotics.
This article provides a comprehensive overview of CRISPR interference (CRISPRi) as a transformative tool for dissecting and controlling bacterial biofilm regulatory networks.
This article provides a comprehensive overview of how CRISPR-based functional genomics is revolutionizing our understanding and control of bacterial biofilms.
This article synthesizes current research on the intricate bidirectional relationship between CRISPR-Cas systems and quorum sensing (QS) in regulating bacterial biofilm formation, a key driver of antimicrobial resistance.
This article provides a comprehensive analysis of CRISPR-Cas systems, covering their fundamental role as adaptive immune mechanisms in prokaryotes and their transformative applications in biotechnology and medicine.